Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haloeye Hydra PF
- Development stage
- Phase 4
- Lead developer
- Eyekare Kilitch
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
**Haloeye Hydra PF** is a preservative-free ophthalmic lubricant product developed by Eyekare Kilitch for dry eye disease. Each solution contains polyethylene glycol 400 0.4% w/v and propylene glycol 0.3% w/v. The formulation functions as an artificial-tear lubricant, hydrating and coating the ocular surface to reduce friction and provide temporary relief of dry-eye-associated irritation and discomfort. ([eyekarekilitch.com](https://eyekarekilitch.com/product/polyethylene-glycol-400-propylene-glycol-eye-drops/))
- Brand names
- Haloeye Hydra PF
- Other names
- polyethylene glycol 400 + propylene glycol preservative-free eye drops
Beyond the preview
Go deeper on Haloeye Hydra PF.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Haloeye Hydra PF.